Showing results (241-250 of 398) with videos related to
Sort By:
Pageof 40
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1993
Smooth muscle differentiation in human myometrium and uterine leiomyomaA Draeger, A H Graf, A Staudach, et al.Cancer Research|March 1, 1990
Interspecific DNA-mediated transfer and amplification of a gene specifying a Mr 100,000 human melanoma-associated cell surface glycoproteinC D Rosenberg, S Ferrone, C V Hamby, et al.The ISME Journal|November 16, 2012
The unaccounted yet abundant nitrous oxide-reducing microbial community: a potential nitrous oxide sinkChristopher M Jones, Daniel R H Graf, David Bru, et al.Psychoneuroendocrinology|July 2, 2022
Biological aging in maltreated children followed up into middle adulthoodG H Graf, X Li, D Kwon, et al.Bone Reports|June 29, 2016
Bone structure and function in male C57BL/6 mice: Effects of a high-fat Western-style diet with or without trace mineralsMuhammad Nadeem Aslam, Karl J Jepsen, Basma Khoury, et al.Cancer Immunology, Immunotherapy : CII|August 1, 1994
ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon gamma production in interleukin-2-activated T cellsA S Chong, X L Jiang, P Scuderi, et al.Obstetrics and Gynecology|May 1, 1995
The relationship between peak velocity in the fetal descending aorta and hematocrit in rhesus isoimmunizationH Steiner, H Schaffer, D Spitzer, et al.Reproductive Sciences (Thousand Oaks, Calif.)|February 11, 2022
Antenatal Steroids and Cord Blood T-cell Glucocorticoid Receptor DNA Methylation and Exon 1 SplicingJeanette R Carpenter, Kathleen A Jablonski, Jordan Koncinsky, et al.Oncology|January 1, 1982
Combination hormonotherapy with tamoxifen and fluoxymesterone in patients with advanced breast cancer relapsing on hormonotherapyA Goldhirsch, U Leuenberger, H J Ryssel, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients. Swiss Group for Clinical Cancer Research (SAKK)R A Joss, M Bacchi, K Buser, et al.Pageof 40